Skip to Content

Join the 'Uveitis' group to help and get support from people like you.

Uveitis News

Immune-Based Drug May Ease Chronic Eye Condition

Posted 8 Sep 2016 by Drugs.com

WEDNESDAY, Sept. 7, 2016 – People with chronic eye inflammation known as uveitis may be able to keep the condition at bay with the immune-suppressing drug Humira (adalimumab), a new study finds. "Humira doesn't cure uveitis, but it does cause it to become quiet," said lead researcher Dr. Glenn Jaffe. He's a professor of ophthalmology at Duke University School of Medicine in Durham, N.C., and a consultant for Humira's maker, AbbVie. "The hope is while the disease is in a quiet state, the disease activity just burns itself out – but it can also come back," he said. The U.S. Food and Drug Administration approved Humira for the treatment of uveitis in June. The results of the study were published Sept. 8 in the New England Journal of Medicine. The study was funded by AbbVie. Uveitis – a term used to describe a group of inflammatory diseases inside the eye – can cause loss of vision and ... Read more

Related support groups: Prednisone, Eye Conditions, Humira, Methylprednisolone, Prednisolone, Hydrocortisone, Medrol, Cortisone, Dexamethasone, Triamcinolone, Betamethasone, Budesonide, Decadron, Entocort, Uveitis, Solu-Medrol, Entocort EC, Cortef, Medrol Dosepak, Celestone

Improper Use of Contact Lenses Can Trigger Serious Eye Damage, CDC Says

Posted 18 Aug 2016 by Drugs.com

THURSDAY, Aug. 18, 2016 – Unsafe use of contact lenses – such as sleeping with them in place or using the same pair for too long – is triggering serious eye injuries for many Americans, a new report finds. In fact, eye damage occurred in nearly 20 percent of contact lens-related eye infections reported to the U.S. Food and Drug Administration over 10 years, researchers say. "Improper wear and care of contact lenses can cause eye infections that sometimes lead to serious, long-term damage," Michael Beach, who directs the Healthy Water Program at the U.S. Centers for Disease Control and Prevention, said in an agency news release. One eye specialist believes many Americans don't take contact lens hygiene seriously enough. "There is a serious health crisis with contact lens-related eye injuries," said Dr. Mark Fromer, an ophthalmologist at Lenox Hill Hospital in New York City. ... Read more

Related support groups: Eye Conditions, Eye Dryness/Redness, Uveitis, Conjunctivitis, Keratitis, Corneal Ulcer, Eye Redness/Itching, Corneal Abrasion, Dry Eye Disease, Keratoconjunctivitis

Routine Eye Exams See Vision Problems You Miss

Posted 14 Jul 2016 by Drugs.com

WEDNESDAY, July 13, 2016 – Routine eye checkups often pick up unnoticed problems, particularly in older adults, a new study says. "In asymptomatic patients, comprehensive routine optometric eye examinations detect a significant number of new eye conditions and/or results in management changes," said the study's author, Elizabeth Irving, and her colleagues from the University of Waterloo in Ontario, Canada. More than half of people with no new symptoms or vision problems receive new prescriptions or treatment changes as a result of routine eye exams, the researchers found. The need for vision prescription changes was found for two out of five people, the study noted. Meanwhile, 16 percent were diagnosed with a new eye condition and 31 percent had a change in their ongoing care, researchers found. The study included data on nearly 6,400 patients who visited a university eye clinic over ... Read more

Related support groups: Eye Conditions, Glaucoma, Cataract, Glaucoma (Open Angle), Macular Degeneration, Uveitis, Iritis, Keratitis, Optic Nerve Disorder, Ocular Herpes Simplex, Macular Edema, Corneal Ulcer, Corneal Abrasion, Retinal Disorders, Glaucoma/Intraocular Hypertension, Diagnosis and Investigation, Strabismus, Chorioretinitis, Glaucoma (Narrow Angle), Visual Defect/Disturbance

AbbVie's Humira (adalimumab) Receives FDA Approval to Treat Adults with Non-Infectious Intermediate, Posterior and Panuveitis

Posted 2 Jul 2016 by Drugs.com

NORTH CHICAGO, Ill., June 30, 2016 /PRNewswire/ – AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Humira (adalimumab) for the treatment of non-infectious intermediate, posterior and panuveitis. Humira is now the first and only FDA-approved non-corticosteroid therapy available for adults with non-infectious intermediate, posterior and panuveitis. This approval marks the 10th approved indication for Humira in the United States for immune-mediated diseases. This month, the European Commission also approved Humira in the European Union for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid-sparing, or in whom corticosteroid treatment is inappropriate. "We are pleased to ... Read more

Related support groups: Humira, Uveitis, Humira Pen, Adalimumab, Uveitis (Posterior), Panuveitis

Zika Can Also Strike Eyes of Adults: Report

Posted 23 Jun 2016 by Drugs.com

WEDNESDAY, June 22, 2016 – Doctors in Brazil report that a man infected with Zika developed a potentially severe eye condition, in another sign that the dreaded virus can harm vision in both babies and adults. "Zika patients should report every single symptom to their doctors, especially if they present with any kind of eye symptoms," said report co-author Dr. Benedito Antonio Lopes da Fonseca, an associate professor at the University of Sao Paulo. The patient, who was in his early 40s, recovered from the condition called uveitis, a kind of inflammation in the eye. But the condition can lead to cataracts and high blood pressure in the eye, said report lead author Dr. Joao Furtado, an infectious disease specialist and professor at the University of Sao Paulo. The mosquito-borne Zika virus has struck countries around the world, and travelers have brought it to the U.S. mainland. The ... Read more

Related support groups: Eye Conditions, Uveitis, Uveitis (Posterior), Uveitis (Anterior), Zika Virus Infection, Visual Defect/Disturbance, Infectious Posterior Uveitis, Infectious Anterior Uveitis

Ebola Survivors May Develop Eye Disease

Posted 7 May 2015 by Drugs.com

THURSDAY, May 7, 2015 – An American doctor who survived Ebola had traces of the virus in his eye fluid long after it was no longer present in his blood, his physicians say. The finding suggests that other Ebola survivors should be monitored for possible Ebola-related eye problems, the doctors report in a new case study. "The thousands of Ebola survivors in West Africa and health care workers in their home countries will need to be monitored for eye disease in the post-Ebola period," said Dr. Steven Yeh, of the Emory Eye Center in Atlanta. The patient is Dr. Ian Crozier, an infectious disease specialists who went to Sierra Leone last August to help with the Ebola outbreak in West Africa. He contracted Ebola within a few weeks and was evacuated to Emory University Hospital, where he arrived in critical condition. During his recovery, Crozier developed severe uveitis, an inflammation of ... Read more

Related support groups: Eye Conditions, Uveitis, Ebola Hemorrhagic Fever, Visual Defect/Disturbance

Allergan Receives FDA Approval for Ozurdex as Treatment Option for Non-Infectious Uveitis Affecting the Posterior Segment of the Eye

Posted 29 Sep 2010 by Drugs.com

IRVINE, Calif.--(BUSINESS WIRE)--Sep 24, 2010 - Allergan, Inc. today announced that the United States Food and Drug Administration (FDA) has approved Ozurdex (dexamethasone intravitreal implant) 0.7 mg for the treatment of non-infectious ocular inflammation, or uveitis, affecting the posterior segment of the eye. Uveitis is characterized by inflammation of the eye's uvea, which is the middle vascular layer consisting of the iris (anterior), ciliary body (intermediate) and choroid (posterior). Uveitis of the anterior (front) of the uvea is more common and typically does not lead to vision impairment;1 while posterior uveitis (back of the eye) is associated with more severe outcomes that can include blindness, cataracts, secondary glaucoma and macular abnormalities.2 Posterior uveitis is the cause of 10 to 15 percent of cases of blindness in the United States.3 Ozurdex is a biodegradable ... Read more

Related support groups: Uveitis, Ozurdex, Uveitis (Posterior)

Ask a Question

Further Information

Related Condition Support Groups

Cyclitis, Uveitis (Posterior), Uveitis (Anterior), Panuveitis, Iritis

Related Drug Support Groups

methotrexate, Remicade, cortisone, triamcinolone, sulfasalazine, Imuran, azathioprine, TobraDex, homatropine, view more... Durezol, mycophenolate mofetil, Zylet, fluocinolone, Maxitrol, infliximab, Azulfidine, Acthar, Acth, Ozurdex, Kenalog-40, Sulfazine, etanercept, Acthar Gel, HP, Cyclogyl, cyclopentolate, dexamethasone / tobramycin, Retisert, Blephamide, dexamethasone / neomycin / polymyxin b, Triesence, hydrocortisone / neomycin / polymyxin b, Azasan, Tobradex ST, loteprednol / tobramycin, AK-Cide, Isopto Homatropine, Neo-Poly-Dex, Maxidex, Atropine-Care, corticotropin, Ak-Pentolate, Poly-Dex, difluprednate, dexamethasone / neomycin, Vexol, Isopto Atropine, Dexacine, Supred, Medasulf, Ocu-Lone C, Ocu-Trol, Sulster, Metimyd, bacitracin / hydrocortisone / neomycin / polymyxin b, Isopto Cetapred, Cetapred, AK-Dex, Neo / PolyB / HC, Neo-Poly-Bac, AK-Trol, Trivaris, Neo-Polycin HC, Cortomycin Suspension, Ocu-Cort, Neotricin HC, Decadron Ocumeter, Ocu-Dex, FML-S Liquifilm, Atrosulf-1, Vasocidin, Blephamide SOP, Homatropaire, Azulfidine EN-tabs, Clinacort, Cortone Acetate, FML-S, Dexasol, prednisolone / sulfacetamide sodium, neomycin / polymyxin b / prednisolone, rimexolone, gentamicin / prednisolone, fluorometholone / sulfacetamide sodium, Cylate, Pentolair, AK-Neo-Dex, Neo-Decadron Ocumeter, Neo-Dex, Neo-Dexair, Dexasporin, Dexacidin, Neo-Decadron, Pred-G, Atropisol, Ocu-Pentolate, Ocu-Tropine, Poly-Pred, Pred-G SOP, Methadex